Drug Profile
Research programme: viral vaccines - Opus Bio
Alternative Names: Hepatitis C vaccine-like particle (VLP) vaccine - Lentigen; LG 611; LG 811; LG 912; LG 970Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Lentigen Corporation
- Developer Epixis; International AIDS Vaccine Initiative; Opus Bio
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C; HIV infections; Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in USA (Parenteral, Infusion)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in USA (Parenteral)